We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Lays Out Preliminary Changes to Agency Restructure
EMA Lays Out Preliminary Changes to Agency Restructure
May 22, 2013
To improve engagement between the European Medicines Agency (EMA), drugmakers and scientific committees, the agency is putting in motion planned changes discussed late last year.